Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kuo

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Immunity, Inflammation and Disease|November 25, 2020
Impaired interferon-α expression in plasmacytoid dendritic cells in asthmaTing-Yu Lin, Chun-Yu Lo, Kuo-Chien Tsao, et al.
Cancers|July 27, 2022
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with DenosumabHow-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang, et al.
The European Respiratory Journal|February 10, 2017
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
BMC Pulmonary Medicine|January 13, 2021
Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary diseaseYu-Chen Huang, Ting-Yu Lin, Hau-Tieng Wu, et al.
Thoracic Cancer|October 16, 2019
Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression controlShih-Hao Huang, Allen Chung-Cheng Huang, Chin-Chou Wang, et al.
Cancers|January 21, 2022
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor MutationChih-Hsi Scott Kuo, Tzu-Hsuan Chiu, Pi-Hung Tung, et al.
Scientific Reports|March 16, 2022
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasisTzu-Hsuan Chiu, Pi-Hung Tung, Chi-Hsien Huang, et al.
American Journal of Cancer Research|October 11, 2023
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancerChien-Yu Lin, Yun-Tse Chou, Po-Lan Su, et al.
Therapeutic Advances in Medical Oncology|August 11, 2021
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancerAllen Chung-Cheng Huang, Chi-Hsien Huang, Jia-Shiuan Ju, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
Lung Cancer in Republic of ChinaYung-Hung Luo, Chao-Hua Chiu, Chih-Hsi Scott Kuo, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Immunity, Inflammation and Disease|November 25, 2020
Impaired interferon-α expression in plasmacytoid dendritic cells in asthmaTing-Yu Lin, Chun-Yu Lo, Kuo-Chien Tsao, et al.
Cancers|July 27, 2022
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with DenosumabHow-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang, et al.
The European Respiratory Journal|February 10, 2017
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
BMC Pulmonary Medicine|January 13, 2021
Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary diseaseYu-Chen Huang, Ting-Yu Lin, Hau-Tieng Wu, et al.
Thoracic Cancer|October 16, 2019
Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression controlShih-Hao Huang, Allen Chung-Cheng Huang, Chin-Chou Wang, et al.
Cancers|January 21, 2022
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor MutationChih-Hsi Scott Kuo, Tzu-Hsuan Chiu, Pi-Hung Tung, et al.
Scientific Reports|March 16, 2022
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasisTzu-Hsuan Chiu, Pi-Hung Tung, Chi-Hsien Huang, et al.
American Journal of Cancer Research|October 11, 2023
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancerChien-Yu Lin, Yun-Tse Chou, Po-Lan Su, et al.
Therapeutic Advances in Medical Oncology|August 11, 2021
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancerAllen Chung-Cheng Huang, Chi-Hsien Huang, Jia-Shiuan Ju, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
Lung Cancer in Republic of ChinaYung-Hung Luo, Chao-Hua Chiu, Chih-Hsi Scott Kuo, et al.
Pageof 4